Chronic obstructive pulmonary disease is a heterogeneous disease that is physiologically defined by irreversible loss of lung function. The natural history of COPD is characterized by episodic accentuation of symptoms, exacerbations, which occur in some but not all COPD subjects. COPD exacerbations are a significant public health concern with significant medical, social, and fiscal consequences. As the genetic determinants of exacerbation frequency are unknown, the scientific goal of this project is to study the association of polymorphic variation in innate immunity genes with exacerbations of COPD. We hypothesize that genes involved in innate immunity, the first line of host defense against infection through microbial recognition, influence the susceptibility to develop COPD exacerbations. To test this hypothesis, we will perform genetic association analyses in two ethnically different, community-based populations. We have genotyped a panel of 352 single nucleotide polymorphisms (SNPs) in 51 innate immunity genes and performed association analysis for COPD exacerbations in a subset of participants in the National Emphysema Treatment Trial (NETT). We have selected the most promising 66 SNPs for further study. We will genotype these 66 SNPs in 29 candidate innate immunity genes among subjects with the frequent versus infrequent COPD exacerbation phenotypes in the Fallen HMO/Harvard Vanguard Medical Associates COPD Exacerbation Study;individuals of primarily European descent. Additionally, we will develop a cohort of African American COPD subjects in Atlanta, GA and identify epidemiological predictors of COPD exacerbation frequency. Subsequently, we will test for genetic association of innate immunity genes with COPD exacerbations in this African American cohort, replicating the associations identified in the two Caucasian cohorts. As African Americans are traditionally underrepresented in medical research, the Atlanta cohort will provide a repository of genotypic and phenotypic information that will facilitate future hypothesis testing. By identifying genetic determinants of COPD exacerbations in multiple cohorts, this proposal could greatly contribute to our understanding of the pathogenesis of COPD exacerbations, the similarities and dissimilarities across different groups, and provide insight into the escalating rates for emergency room visits, hospitalizations, and death in African Americans with COPD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01HL092601-05
Application #
8294953
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Tigno, Xenia
Project Start
2008-07-15
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2014-06-30
Support Year
5
Fiscal Year
2012
Total Cost
$142,045
Indirect Cost
$10,522
Name
Morehouse School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
102005451
City
Atlanta
State
GA
Country
United States
Zip Code
30310
Wan, Emily S; Qiu, Weiliang; Carey, Vincent J et al. (2015) Smoking-Associated Site-Specific Differential Methylation in Buccal Mucosa in the COPDGene Study. Am J Respir Cell Mol Biol 53:246-54
Criner, Gerard J; Bourbeau, Jean; Diekemper, Rebecca L et al. (2015) Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 147:883-93
Criner, Gerard J; Bourbeau, Jean; Diekemper, Rebecca L et al. (2015) Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 147:894-942
Parker, Margaret M; Foreman, Marilyn G; Abel, Haley J et al. (2014) Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study. Genet Epidemiol 38:652-9
Bhatt, Surya P; Wells, James M; Kim, Victor et al. (2014) Radiological correlates and clinical implications of the paradoxical lung function response to ?? agonists: an observational study. Lancet Respir Med 2:911-8
Hobbs, Brian D; Foreman, Marilyn G; Bowler, Russell et al. (2014) Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease. Ann Am Thorac Soc 11:1387-94
Kamil, Firas; Pinzon, Ingrid; Foreman, Marilyn G (2013) Sex and race factors in early-onset COPD. Curr Opin Pulm Med 19:140-4
Foreman, Marilyn G; Kong, Xiangyang; DeMeo, Dawn L et al. (2011) Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 44:316-22
Foreman, Marilyn G; Zhang, Lening; Murphy, James et al. (2011) Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 184:414-20
Wan, Emily S; DeMeo, Dawn L; Hersh, Craig P et al. (2011) Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD). Respir Med 105:588-94